Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
4,299
NCT00163280
Safety, Tolerability and Efficacy of ATL-104 in Oral Mucositis
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 31, 2004
Completion: Dec 31, 2005
NCT00156897
Efficacy and Safety of ATL-962 in Obese Diabetics
Start: Dec 31, 2004
Completion: Oct 31, 2005
NCT00148382
Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects
Phase: Phase 1
Start: Apr 30, 2005
Completion: Jul 31, 2005
NCT00268879
Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)
Phase: Phase 3
Start: Dec 31, 2005
Completion: Jan 31, 2008
NCT00299013
Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis
Start: Mar 31, 2006
Completion: Apr 30, 2008
NCT00607971
Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Start: Apr 30, 2006
Completion: Jun 30, 2008